We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Credit Card-Sized Test Boosts TB Detection in HIV Hotspots

By LabMedica International staff writers
Posted on 30 Jun 2025

Current tuberculosis (TB) tests face major limitations when it comes to accurately diagnosing the infection in individuals living with HIV. More...

HIV, a frequent co-infection with TB, complicates detection by eliminating the very immune cells that many traditional TB tests depend on to flag the infection. While over 90% of the estimated 2 billion global TB cases remain latent—showing no symptoms and posing no transmission risk—the compromised immune systems of HIV-positive individuals can cause latent TB to become active. This transformation significantly raises the risk of further transmission and frequently leads to fatal outcomes. In fact, TB stands as the primary cause of death among people with HIV across the globe. Now, a newly developed handheld diagnostic tool offers a major advancement, significantly improving TB detection in HIV-infected individuals, according to research published in Nature Biomedical Engineering.

The portable device, developed at Tulane University (New Orleans, LA, USA), operates without electricity and is driven by a beetle-inspired chemical reaction. It addresses a persistent gap in the detection of TB among HIV-positive individuals, a gap that has long hindered global TB eradication efforts. To overcome the limitations posed by HIV-related immune suppression, researchers identified two new biomarkers that can reveal TB infection independently of the immune cells typically targeted by the virus. Named ASTRA (Antigen-Specific T-cell Response Assay), this compact, credit card-sized device requires just a single drop of blood and can deliver same-day diagnostic results without the need for laboratory infrastructure or skilled technicians. Once a drop of blood is added, the test must incubate for four hours, during which a built-in reagent stimulates immune cells. This reagent acts like a “wanted poster,” prompting the immune cells to respond if they’ve previously encountered TB bacteria.

To eliminate the need for electricity, researchers took inspiration from the bombardier beetle, which defends itself by mixing two chemicals that produce a forceful spray. Similarly, the ASTRA device uses a pair of chemicals that react to push the sample through a microchip for final analysis. The test delivers results in approximately four hours, significantly faster than the commonly used IGRA (Interferon-Gamma Release Assay), which requires 24 hours, and the TB skin test, which can take two to three days to yield a diagnosis. The effectiveness of ASTRA was validated using blood samples from individuals in Eswatini, a country with high TB incidence and the world’s highest known HIV prevalence (27.3%). Compared to IGRA, ASTRA demonstrated 87% specificity in detecting TB among HIV-infected individuals, markedly outperforming IGRA’s 60%. The device also surpassed IGRA in detecting TB in patients without HIV, underscoring its broader diagnostic potential.

“Current tests such as the IGRA are cost-prohibitive or require access to facilities that resource-limited communities don’t have. If we are going to eliminate TB, we have to diagnose and treat as many infection cases as possible,” said senior author Tony Hu, PhD, Weatherhead Presidential Chair in Biotechnology Innovation at Tulane University and director of the Tulane Center for Cellular & Molecular Diagnostics. “The sooner you have a diagnosis, the sooner you can begin the process of determining proper treatment. TB is the No. 1 pathogen HIV patients worry about globally. If treatment is available, we should be working to kill these bacteria, latent or not.”

Related Links:
Tulane University


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Rapid Molecular Testing Device
FlashDetect Flash10
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: A diagnostic test can distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone (Photo courtesy of University of Turku)

Novel Diagnostic Tool to Revolutionize Treatment Guidance of Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a solid tumor type commonly treated with surgery. However, there has been no clinically available method to determine which patients can be cured with surgery... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.